AG00I8WU

50-18-0 | 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin 2-oxide

Chemical structure of 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin 2-oxide, CAS 50-18-0
AG00I8WU
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 50-18-0
Catalog Number AG00I8WU(AGN-PC-0S6UBQ)
Chemical Name 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin 2-oxide
EC Number 200-015-4
IUPAC Name N,N-bis(2-chloroethyl)-2-oxo-1,3,2λ5-oxazaphosphinan-2-amine
InChI InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)
InChI Key CMSMOCZEIVJLDB-UHFFFAOYSA-N
MDL Number MFCD00149395
Molecular Formula C7H15Cl2N2O2P
Molecular Weight 261.0860
RTECS Number RP5950000
SMILES ClCCN(P1(OCCCN1)=O)CCCl
Synonyms
(+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate, B 518, B-518, B518, Cyclophosphamide, Cyclophosphamide Anhydrous, Cyclophosphamide Monohydrate, Cyclophosphamide, (R)-Isomer, Cyclophosphamide, (S)-Isomer, Cyclophosphane, Cytophosphan, Cytophosphane, Cytoxan, Endoxan, Neosar, NSC 26271, NSC-26271, NSC26271, Procytox, Sendoxan, cyclophosphamide, 50-18-0, Cyclophosphamid, Cyclophosphane, Cytophosphan, Procytox, Clafen, Cytoxan, Endoxan, Neosar, Cyclophosphamidum, Cyclophosphan, Cyclostin, Sendoxan, Cytophosphane, Claphene, Endoxana, Endoxanal, Genoxal, Endoxan-Asta, Endoxan R, Zyklophosphamid, Mitoxan, (RS)-Cyclophosphamide, Cyclophosphoramide, Cyklofosfamid, Endoxane, Enduxan, Semdoxan, Senduxan, (+-)-Cyclophosphamide, Ciclofosfamida, Cyclofosphamide, Cyclophosphanum, Ciclophosphamide, Lyophilized Cytoxan, Cyclophosphamide anhydrous, Rcra waste number U058, Asta B 518, Cycloblastin, D,L-Cyclophosphamide, ASTA, Cyklofosfamid [Czech], Ciclophosphamide [INN], NSC 26271, Zyklophosphamid [German], Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester, B 518, CB 4564, NCI-C04900, Cyclophosphamide (anhydrous), SK 20501, ASTA B518, Ciclofosfamida [INN-Spanish], 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, NSC-26271, Cyclophosphamidum [INN-Latin], N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide, Occupation, cyclophosphamide exposure, CCRIS 188, Revimmune, (-)-Cyclophosphamide, 4-Hydroxy-cyclophosphan-mamophosphatide, CHEBI:4027, Cyclophosphamide (anhydrous form), HSDB 3047, N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide, NSC26271, Cytoxan (TN), EINECS 200-015-4, RCRA waste no. U058, BRN 0011744, 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide, AI3-26198, 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin, 2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide, CMSMOCZEIVJLDB-UHFFFAOYSA-N, N,N-Bis(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide, N,N-Di(2-chloroethyl)-N,O-propylene-phosphoric acid ester diamide, Phosphorodiamidic acid, N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, intramol. ester, CY, N,N-bis(2-chloroethyl)-2-oxo-1,3,2$l^{5}-oxazaphosphinan-2-amine, N,N-Bis(beta-chloroethyl)-N',O-propylenephosphoric acid ester diamide, N,N-Bis(beta-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide, EN300-74526, 2-(Bis(2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazophosphorine 2-oxide, N,N-Bis-(beta-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid [German], 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (+-)-, W-105248, Cyclophosphamides, Cytoxan Lyoph, 2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-, 2-oxide, Cyclophosphamide (TN), Cyclophosphamide Sterile, Cyclophosphamide (INN), Clafen(Cyclophosphamide), SR-01000075737, NCGC00015209-05, Cyclophosphamide [USP:INN], Ciclofosfamide, Ledoxina, 2-(Bis(2-chloroethyl)amino)-2H-1,2-oxazaphosphorine 2-oxide, 2-[Bis(2-chloroethyl)amino]-2H-1,2-oxazaphosphorine 2-oxide, B-518, Cyclophosphamide, (+-)-Isomer, Lyophilizedcytoxan, (Bis(chloro-2-ethyl)amino)-2-tetrahydro-3,5,6-oxazaphosphorine-1,3,2-oxide-2 hydrate, [Bis(chloro-2-ethyl)amino]-2-tetrahydro-3,5,6-oxazaphosphorine-1,3,2-oxide-2 hydrate, 60007-96-7, CB-4564, Spectrum_000858, AC1L1EQQ, Anhydrous cyclophosphamide, CHEMBL88, Spectrum2_001146, Spectrum3_000370, Spectrum4_000304, Spectrum5_000795, Clafen(Cyclophosphamide)/, Lopac-C-0768, Epitope ID:131782, C 0768, SCHEMBL4346, (.+/-.)-Cyclophosphamide, Lopac0_000238, BSPBio_002099, KBioGR_000888, KBioSS_001338, bis(2-Chloroethyl)phosphami de cyclic propanolamide, ARONIS24566, DivK1c_000246, SPBio_001071, GTPL7154, SCHEMBL4345553, bis(2-Chloroethyl)phosphamide cyclic propanolamide ester, DTXSID5020364, SCHEMBL10262910, CMSMOCZEIVJLDB-UHFFFAOYSA-, CTK2F5582, KBio1_000246, KBio2_001338, KBio2_003906, KBio2_006474, KBio3_001319, KS-00000XHN, BBC/739, CYCLOPHOSPAMIDE MONOHYDRATE, WLN: T6MPOTJ BO BN2G2G, NINDS_000246, 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine, HMS2090A12, HMS3260P17, HMS3715J05, Pharmakon1600-01500213, BCP02139, ZX-AS004939, Tox21_500238, ABP000629, BBL022697, MFCD00005978, N,N-Bis-(beta-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid, NSC273033, NSC273034, NSC756711, STK177249, AKOS005410738, AN-6966, API0002151, CS-1425, DB00531, LP00238, LS-1302, MCULE-5327530727, NSC-273033, NSC-273034, NSC-756711, (+-)-N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide, IDI1_000246, N,3,2-oxazaphosphorin-2-amine-2-oxide, N,O-propylen-phosphorsaeure-ester-diamid, NCGC00015209-01, NCGC00015209-02, NCGC00015209-03, NCGC00015209-04, NCGC00015209-06, NCGC00015209-07, NCGC00015209-08, NCGC00015209-09, NCGC00015209-12, NCGC00091741-02, NCGC00091741-03, NCGC00260923-01, 60007-95-6, ACM173547450, BC200624, HY-17420, LS-99787, NCI60_002097, OR322611, SC-22408, SC-47258, SC-91286, N,O-propylenephosphoric acid ester diamide, SBI-0050226.P003, 2-(4-FLUOROPHENYL)CYCLOPROPYL]AMINE, AB0007927, N,O-propylene-phosphoric acid ester diamide, TC-063558, TR-037249, A2343, EU-0100238, FT-0624276, N,O-trimethylenephosphoric acid ester diamide, ST51005945, 3356-EP2269989A1, 3356-EP2270001A1, 3356-EP2270008A1, 3356-EP2270014A1, 3356-EP2270018A1, 3356-EP2270505A1, 3356-EP2272822A1, 3356-EP2272825A2, 3356-EP2272827A1, 3356-EP2275102A1, 3356-EP2275412A1, 3356-EP2275413A1, 3356-EP2275420A1, 3356-EP2277865A1, 3356-EP2277876A1, 3356-EP2280012A2, 3356-EP2281815A1, 3356-EP2281818A1, 3356-EP2287156A1, 3356-EP2289892A1, 3356-EP2289894A2, 3356-EP2292233A2, 3356-EP2292595A1, 3356-EP2292614A1, 3356-EP2292615A1, 3356-EP2292617A1, 3356-EP2295055A2, 3356-EP2295412A1, 3356-EP2295413A1, 3356-EP2295416A2, 3356-EP2295426A1, 3356-EP2295427A1, 3356-EP2298743A1, 3356-EP2298746A1, 3356-EP2298748A2, 3356-EP2298764A1, 3356-EP2298765A1, 3356-EP2298767A1, 3356-EP2298768A1, 3356-EP2298772A1, 3356-EP2298778A1, 3356-EP2298780A1, 3356-EP2301928A1, 3356-EP2301933A1, 3356-EP2305250A1, 3356-EP2305640A2, 3356-EP2305642A2, 3356-EP2305671A1, 3356-EP2305677A1, 3356-EP2305689A1, 3356-EP2308812A2, 3356-EP2308833A2, 3356-EP2308839A1, 3356-EP2308855A1, 3356-EP2308861A1, 3356-EP2311453A1, 3356-EP2311807A1, 3356-EP2311808A1, 3356-EP2311825A1, 3356-EP2311827A1, 3356-EP2311829A1, 3356-EP2311837A1, 3356-EP2311840A1, 3356-EP2311842A2, 3356-EP2314587A1, 3356-EP2314590A1, 3356-EP2316831A1, 3356-EP2316832A1, 3356-EP2316833A1, 3356-EP2316834A1, 3356-EP2371811A2, 3356-EP2374454A1, C07888, D07760, W-5035, 27353-EP2269998A2, 27353-EP2272516A2, 27353-EP2275404A1, 27353-EP2275469A1, 27353-EP2284171A1, 27353-EP2287940A1, 27353-EP2292227A2, 27353-EP2295550A2, 27353-EP2298762A2, 27353-EP2298768A1, 27353-EP2308839A1, 27353-EP2314587A1, 27353-EP2371795A1, AB00053446-09, AB00053446-11, AB00053446-12, AB00053446_13, AB00053446_14, AB00053446_15, 005C978, 110841-EP2272827A1, 110841-EP2298305A1, 139301-EP2270008A1, 139301-EP2292617A1, W-60377, N,O-propylenephosphoric acid ester amide monohydrate, SR-01000075737-1, SR-01000075737-6, BRD-A09722536-002-02-4, UNII-6UXW23996M component CMSMOCZEIVJLDB-CQSZACIVSA-N, 2-(bis(2-chloroethyl)amino)-1,3,2-oxazaphosphinane 2-oxide, 2-[BIS(2-CHLOROETHYL)AMINO]TETRAHYDRO-2H-1,3,2-OXA, 2-[bis(2-chloroethyl)amino]-1,3,2$l;{5}-oxazaphosphinan-2-one, 2-[bis(2-chloroethyl)amino]-1,3,2-oxazaphosphaperhydroin-2-one, N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide #, 2-(bis(2-Chloroethyl)-amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide, 2-(di(2-chloroethyl)amino)-1-oxa-3-aza-2-phosphacyclohexane 2-oxide, 2-(Di(2-chloroethyl)amino)-2-phospha(V)-tetrahydro-2H-1,3-oxazine-2-one, 2-[Bis(2-chloroethyl)amino]tetrahydro-1,3,2-oxazaphosphorin-2-oxide, 2H-1,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, 2H-1,3,2-Oxazaphosphorine, 2-(bis(2-chloroethyl)amino)tetrahydro-,2-oxide, N,N-Bis(.beta.-chloroethyl)-N',O-trimethylenephosphoric acid ester diamide, N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide (H2O), N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine-2-oxide, N,N-Bis-(.beta.-chloraethyl)-N',O-propylen-phosphorsaeure-ester-diamid, N-bis(beta-Chloroethyl)-N'O,trimethylenephos phoric acid ester diamide, N-bis(beta-Chloroethyl)-N'O,trimethylenephosphoric acid ester diamide, tatrahydro-2-(Bis(2-chloroethyl)amino)-2H-1,3,2-oxazaphosphorine 2-oxide, (+/-)-2-[Bis(2-chloroethyl)amino]tetrahydro-2 H-1,3,2-oxazaphosphorine 2-oxide, (R)-2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorin 2-oxide, (S)-2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide, 2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, 2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (+)-, 2H-1,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (-)-, 2H-1,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide (9CI), 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-,2-oxide, N,N-bis(2-chloroethyl)-2-oxo-1-oxa-3-aza-2$l^{5}-phosphacyclohexan-2-amine, N,N-bis(2-chloroethyl)-N'-(3-h ydroxypropyl)phosphorodiamidic acid intramol. ester, N,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)phosphorodiamidic acid intramol. ester, N,N-Bis(2-Chloroethyl)tetrahydro-2H-1,3,2-Oxazaphosphorin-2-Amine, 2-Oxide, Phosphorodiamidic acid,N-bis(2-chloroethyl)-N'-(3-hydroxypropyl)-, intramol. ester, te trahydro-N,N-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide, tetrahydro-N,N-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide, InChI=1/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12), Hexadrin, Cyclophosphamide monohydrate, cyclophosphamid-, D-Cyclophosphamide, L-Cyclophosphamide, Cyclophosphamide hydrate, Revimmune (TN), Procytox (TN), Cyclophosphamide-d4, Endoxan (TN), Neosar (TN), (R)-Cyclophosphamide, (S)-Cyclophosphamide, (+)-Cyclophosphamide, Cyclophosphamide [USP], C7H15Cl2N2O2P, D0CT9C, UNII-6UXW23996M, Cyclophosphamide, (R)-Isomer, Cyclophosphamide, (S)-Isomer, 5,5'-Dideuterocyclophosphamide, CID2907, 6UXW23996M, C7-H15-Cl2-N2-O2-P, NA2811, UN2811, CS-O-15107, BRN 4678992, 6055-19-2, B518, N,N-bis(2-chloroethyl)-2-oxo-1,3,2, C2236, 4-27-00-09750 (Beilstein Handbook Reference), D003520, CTX, -2-[Bis amino]tetrahydro-2H-1,3,2-oxazaphosphorine2-oxide, 2-[Bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide, 60030-72-0, CP, CPA, (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate, 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (R)-, 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide, (S)-, 879324-66-0,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited